Cencora is now targeting an 8% to 10% rise in revenue for the full fiscal year, a lift from its previous guidance for 7% to 9% growth. Sales are expected to rise 9% to 11% in its U.S. healthcare ...

NCR Voyix named Executive Chairman James Kelly as president and chief executive, succeeding incumbent David Wilkinson with immediate effect following a series of deals.